Pages that link to "Q28580328"

The following pages link to Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells (Q28580328):

Displaying 39 items.

• Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells (Q24316364) (← links)
• Receptor Ck-dependent signaling regulates hTERT gene transcription. (Q25255748) (← links)
• Sp1 transactivation of the TCL1 oncogene (Q28214220) (← links)
• Thromboxane A2 receptor (Q28562896) (← links)
• Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells (Q29347056) (← links)
• Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma) (Q33548739) (← links)
• PPAR and immune system--what do we know? (Q34913467) (← links)
• Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors (Q35039274) (← links)
• A novel SP1/SP3 dependent intronic enhancer governing transcription of the UCP3 gene in brown adipocytes (Q35082470) (← links)
• Peroxisome proliferator-activated receptors and the cardiovascular system (Q35173859) (← links)
• PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. (Q35458969) (← links)
• Nuclear receptor-mediated transactivation through interaction with Sp proteins (Q35805048) (← links)
• Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression. (Q35880635) (← links)
• Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function (Q36159034) (← links)
• Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins (Q36447447) (← links)
• The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor (Q36485238) (← links)
• Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents (Q36744694) (← links)
• NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration (Q36811554) (← links)
• Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1 (Q37142538) (← links)
• Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS). (Q37327724) (← links)
• Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1 (Q37482957) (← links)
• In utero exposure to di-(2-ethylhexyl) phthalate induces metabolic disorder and increases fat accumulation in visceral depots of C57BL/6J mice offspring (Q37582176) (← links)
• PPARgamma as a potential therapeutic target in pulmonary hypertension (Q37689190) (← links)
• Peroxisome proliferator-activated receptor gamma in osteoarthritis (Q37785802) (← links)
• PPARγ agonist beyond glucose lowering effect. (Q37857704) (← links)
• Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells (Q38331308) (← links)
• Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor (Q39335219) (← links)
• IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity (Q39772693) (← links)
• Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. (Q40419035) (← links)
• Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. (Q40729006) (← links)
• Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure (Q41362011) (← links)
• New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor (Q42167608) (← links)
• Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator-activated receptor γ (PPARγ) during adipocyte differentiation. (Q42512618) (← links)
• Glypican 4 may be involved in the adipose tissue redistribution in high-fat feeding C57BL/6J mice with peroxisome proliferators-activated receptor γ agonist rosiglitazone treatment (Q42972444) (← links)
• Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma (Q43183944) (← links)
• Induction of PPAR gamma mRNA and protein expression by rosiglitazone in chronic cyclosporine nephropathy in the rat. (Q43196839) (← links)
• Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. (Q44801427) (← links)
• Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells (Q46384794) (← links)
• The influence of conjugated linoleic acid on the expression of peroxisome proliferator-activated receptor-γ and selected apoptotic genes in non-small cell lung cancer (Q93019955) (← links)